Platuhpus

[Platuhpus @platuhpus]

@Splitgate It’s safe to say I have the worst luck in this game 65 contaminate games and I’ve only been on the zombie side. Not getting this weekly done

[Platuhpus @platuhpus]

@Splitgate Cool downs on portals would be awesome. There are people in odd ball that will camp on the top of the maps and have their team spam portals so no one else can get to them. With a cool down this wouldn’t be as bad. Maybe have spawns of emp nades around.

[Platuhpus @platuhpus]

@dosecheck @CBCDay6 What’s your company ticker I want to invest in this!

[Citius Pharma @CitiusPharma]

CEO, Myron Holubiak: "We are pleased with the DMC recommendation to continue this trial without modification. This marks the third recommendation by the DMC supporting the continuation of the Mino-Lok trial."

https://t.co/ZAE0LHWSyP $CTXR #Pharma #Healthcare #ClinicalTrial

[CEO @Investments_CEO]

If you hold more than 2,000 $DOGE you must retweet this! 🤙

[Platuhpus @platuhpus]

@LeahCheshier @Space_Station @Thom_astro @astro_kimbrough I spy with my little eye something flat that everyone thinks is round!

[Platuhpus @platuhpus]

@TeslaOwnersEBay @elonmusk @AustinTeslaClub @MFrunker @TeslaChillMode @CodingMark @ElonAccessories @tesla_raj @orangewheels2 How was your day?

[Citius Pharma @CitiusPharma]

Tune in! Our President and CEO, Myron Holubiak, is presenting at the @Benzinga Global Small Cap Conference today at 1:50 p.m. ET.

Watch here: https://t.co/WloxXciThi $CTXR #Pharma #Healthcare #Science

[Platuhpus @platuhpus]

✨ Participate in our May #Webull wheel event to win awesome prizes! 😍 4000 shares of MSFT stocks are waiting to be claimed. 💙 https://t.co/6dsao14rIj

[Citius Pharma @CitiusPharma]

Doctors Identify Two Distinct Types of #COVID19-Associated Acute Respiratory Distress Syndrome #ARDS

Read the full article via @SciTechDaily1 here: https://t.co/WdqjHOAsON #Healthcare

[Platuhpus @platuhpus]

@CitiusPharma @MDAndersonNews @technology That’s awesome! Looking forward to these phase 3 results!

[Citius Pharma @CitiusPharma]

Our Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. #CRBSIs are very serious, especially in cancer #patients receiving therapy through central venous catheters.

https://t.co/RdRGQonfg6 $CTXR #Health #Pharma

[Platuhpus @platuhpus]

@CitiusPharma with the vote coming into place I see a lot of people concerned that the company is trying to dilute their shares. Will you guys create a video fully explaining what the vote is for, some people have a hard time reading docs and easier with hearing it.

[Citius Pharma @CitiusPharma]

~100,000 women undergo post-mastectomy reconstructive breast #surgery. Our early-stage development project Mino-Wrap slowly dissolves in situ, providing extended protection against #infection.

https://t.co/5TSvq3QWZR $CTXR #Health #Medical #Science

[Citius Pharma @CitiusPharma]

Patients with short-term #catheters often have underlying coagulopathy, where the blood’s ability to clot is impaired. This makes reinsertion of a new #CVC at a different site is risky. Through Mino-Lok, we are working to combat this unmet need.

https://t.co/N06M2D705O $CTXR

[Platuhpus @platuhpus]

@CitiusPharma @Benzinga Very exciting stuff! Look forward to seeing more.

[Platuhpus @platuhpus]

@CitiusPharma @Benzinga Good job on the interview! Can’t wait for the future I know I won’t be in the pool of people looking back and saying I wish I would have invested.

[Citius Pharma @CitiusPharma]

Pursuing a New Standard of Care $CTXR #Healthcare #Biotech #Pharma #Science #Innovation #Pharmaceutical #Biopharma #Health

Learn more about Citius here https://t.co/5H0PhncLqN

[Platuhpus @platuhpus]

@CitiusPharma What does this mean for the company.. Any type of revenue?

[Citius Pharma @CitiusPharma]

We have recently signed an exclusive worldwide licensing agreement with privately-held Novellus, Inc. for unique stem cell therapy for Acute Respiratory Distress Syndrome (#ARDS) associated with #COVID19.

https://t.co/ZIzlNRyUxO $CTXR #Pharma #Health #Virus #Science